FI890907A - Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi - Google Patents

Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi Download PDF

Info

Publication number
FI890907A
FI890907A FI890907A FI890907A FI890907A FI 890907 A FI890907 A FI 890907A FI 890907 A FI890907 A FI 890907A FI 890907 A FI890907 A FI 890907A FI 890907 A FI890907 A FI 890907A
Authority
FI
Finland
Prior art keywords
chymotrypsin
preparations
disable
immobilised
activator
Prior art date
Application number
FI890907A
Other languages
English (en)
Swedish (sv)
Other versions
FI93696B (fi
FI890907A0 (fi
FI93696C (fi
Inventor
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI890907A0 publication Critical patent/FI890907A0/fi
Publication of FI890907A publication Critical patent/FI890907A/fi
Publication of FI93696B publication Critical patent/FI93696B/fi
Application granted granted Critical
Publication of FI93696C publication Critical patent/FI93696C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI890907A 1988-02-26 1989-02-24 Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi FI93696C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT49488 1988-02-26
AT0049488A AT391810B (de) 1988-02-26 1988-02-26 Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators

Publications (4)

Publication Number Publication Date
FI890907A0 FI890907A0 (fi) 1989-02-24
FI890907A true FI890907A (fi) 1989-08-27
FI93696B FI93696B (fi) 1995-02-15
FI93696C FI93696C (fi) 1995-05-26

Family

ID=3492093

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890907A FI93696C (fi) 1988-02-26 1989-02-24 Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi

Country Status (9)

Country Link
US (2) US5094949A (fi)
EP (1) EP0330647B1 (fi)
JP (1) JPH07116052B2 (fi)
AT (2) AT391810B (fi)
CA (1) CA1338499C (fi)
DE (1) DE58905495D1 (fi)
DK (1) DK90589A (fi)
ES (1) ES2059826T3 (fi)
FI (1) FI93696C (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
MXPA05005328A (es) * 2002-11-25 2005-08-16 Octapharma Ag Fraccion de albumina derivada de plasma con precalicreina empobrecida.
ES2221817B1 (es) 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU469815B2 (en) * 1971-04-14 1973-10-18 Anti-inflammatory compositions
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
DE3249491T1 (de) * 1982-05-31 1984-04-19 Mochida Pharmaceutical Co., Ltd., Tokyo Immobilisiertes Pepsin zur Verwendung beim Entfernen von Immunkomplex aus dem Blut und eine Verfahren zur Entfernung von Immunkomplex aus dem Blut unter Verwendung des immobilisierten Pepsins
AT376367B (de) * 1983-03-16 1984-11-12 Immuno Ag Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators

Also Published As

Publication number Publication date
ES2059826T3 (es) 1994-11-16
DE58905495D1 (de) 1993-10-14
FI93696B (fi) 1995-02-15
US5094949A (en) 1992-03-10
ATE94071T1 (de) 1993-09-15
EP0330647A2 (de) 1989-08-30
CA1338499C (en) 1996-07-30
DK90589A (da) 1989-08-27
US5324628A (en) 1994-06-28
AT391810B (de) 1990-12-10
FI890907A0 (fi) 1989-02-24
EP0330647A3 (en) 1990-05-09
EP0330647B1 (de) 1993-09-08
JPH01261332A (ja) 1989-10-18
JPH07116052B2 (ja) 1995-12-13
DK90589D0 (da) 1989-02-24
FI93696C (fi) 1995-05-26
ATA49488A (de) 1990-06-15

Similar Documents

Publication Publication Date Title
DE69027187D1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
ES2063515T3 (es) Ifn-alfa o-glucosilados.
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE69000248D1 (de) Verwendung von interzellularen adhaesions-molekuelen und deren bindungsliganden bei der behandlung von asthma.
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
ATE54826T1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
FI93696B (fi) Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi
NO890129L (no) Fremgangsmaate ved inaktivering av sykdomsfremkallende materialer i blodplasmaprodukter.
MX9301858A (es) Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv.
DE58906510D1 (de) Immunogen und seine Verwendung zur Gewinnung von Antikörpern gegen Hämoglobin A1C.
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen
DK131284D0 (da) Fremgangsmaade til inaktivering af stoffer,der foraarsager uforenelighedsreaktioner
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
NO179127C (no) Fremgangsmåte for pasteurisering av blodplasma samt blanding for utförelse derav
DE3766258D1 (de) Spiegelndes produkt von goldener faerbung und verfahren zu dessen herstellung.
DE69631528D1 (de) Serumzusammensetzungen zur hemmung von retroviren und tumorwachstum
ATE46520T1 (de) Verfahren zur herstellung von steroiden, insbesondere von zwischenprodukten in der herstellung von proligeston und verwandte zwischenprodukte und neue erhaltene zwischenprodukte.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: IMMUNO AKTIENGESELLSCHAFT